NYSE ARCA | ETF
Top 14 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PAGP | Plains GP Holdings LP | Energy | Oil & Gas Midstream | 22.64% |
| APLT | Applied Therapeutics Inc | Healthcare | Biotechnology | 17.32% |
| TCRX | Tscan Therapeutics Inc | Healthcare | Biotechnology | 7.52% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 5.62% |
| PHAT | Phathom Pharmaceuticals Inc | Healthcare | Biotechnology | 5.01% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 4.85% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 4.48% |
| FULC | Fulcrum Therapeutics Inc | Healthcare | Biotechnology | 3.97% |
| ATHA | Athira Pharma Inc | Healthcare | Biotechnology | 3.7% |
| TSAT | Telesat Corp | Technology | Communication Equipment | 3.06% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 2.88% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 2.8% |
| DAWN | Day One Biopharmaceuticals Inc | Healthcare | Biotechnology | 2.76% |
| HIGH | Simplify Exchange Traded Funds - Simplify Enhanced Income ETF | 2.65% |
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.